Cargando…
Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
Although the incidence of severe cutaneous adverse reactions (SCARs) to medications is very low, SCARs can result in disability or even death if they are not diagnosed and treated properly. As the rapid recognition of SCARs is essential, it is necessary to develop diagnostic markers for them that ca...
Autores principales: | Miyagawa, Fumi, Asada, Hideo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228887/ https://www.ncbi.nlm.nih.gov/pubmed/34204146 http://dx.doi.org/10.3390/biom11060847 |
Ejemplares similares
-
Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists’ Viewpoint
por: Shafiq, Nusrat, et al.
Publicado: (2022) -
Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS)
por: Miyagawa, Fumi, et al.
Publicado: (2021) -
Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature
por: De Luca, Fabrizio, et al.
Publicado: (2017) -
Dynamics of chemokines in severe drug hypersensitivity
por: Asada, Hideo, et al.
Publicado: (2014) -
Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
por: James, Fiona, et al.
Publicado: (2022)